BioStacks

Herb

Piper betle Leaf Extract

Evidence

Limited
Evidence: 2 of 5 (Limited)

What the evidence says

Betel leaf (Piper betle) is distinct from areca/betel nut — the nut, especially when chewed with tobacco, is an IARC Group 1 human carcinogen; the leaf extract itself is not classified as carcinogenic but should not be confused with betel-quid chewing products.

In vitro evidence only; no human RCTs. Important to distinguish from areca/betel nut, a known human carcinogen.

Top Piper betle Leaf Extract supplements

About Piper betle Leaf Extract

Betel leaf (Piper betle) is distinct from areca/betel nut — the nut, especially when chewed with tobacco, is an IARC Group 1 human carcinogen; the leaf extract itself is not classified as carcinogenic but should not be confused with betel-quid chewing products. Evidence for the leaf extract is limited to in vitro antibacterial, antifungal, and antioxidant studies; no human RCTs were identified for any supplement indication. Some extracts show dose-dependent cytotoxicity in lab models, underscoring thin safety data at supplement-relevant concentrations.

What Piper betle Leaf Extract supports

  • Antibacterial/antioxidant activity shown in lab studies only — no human trials, and distinct from carcinogenic betel/areca nut

Clinical evidence

Limited clinical evidence. In vitro evidence only; no human RCTs. Important to distinguish from areca/betel nut, a known human carcinogen.

NIH Fact Sheet